Clinical Trial Update: NOX-100 for Preventing Hypotension During Hemodialysis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating NOX-100 to prevent hypotension during hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension

Drugs mentioned

• NOX-100

Snippet

Sponsor: Medinox, Inc. | Conditions: Hypotension | Phase 2 | Status: COMPLETED